Motofen .025 mg/1
difenoxin and atropine sulfate · TABLET · Legacy Pharma USA Inc.
Motofen is a tablet containing difenoxin and atropine sulfate at .025 mg/1, taken oral. Manufactured by Legacy Pharma USA Inc..
Key Facts
- Brand Name
- Motofen
- Generic Name
- difenoxin and atropine sulfate
- NDC Code (Product)
83107-011- Manufacturer
- Legacy Pharma USA Inc.
- Strength
- .025 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule IV (Controlled)
- Application #
- NDA017744
- Marketing Start
- 01/01/2026
Recall History
No Recall HistoryFrequently Asked Questions
What is Motofen used for?
Motofen contains difenoxin and atropine sulfate. It is a tablet taken oral. Consult your doctor for specific uses.
Is Motofen a controlled substance?
Yes, Motofen is classified as CIV under the DEA Controlled Substances Act.
What is the generic name for Motofen?
The generic name for Motofen is difenoxin and atropine sulfate. There are no other listed brand versions of difenoxin and atropine sulfate.
What is the NDC code for Motofen .025 mg/1?
The NDC (National Drug Code) for Motofen .025 mg/1 is 83107-011, listed by Legacy Pharma USA Inc..
Other Motofen Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)